Analystreport

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) had its price target raised by analysts at Stifel Nicolaus from $16.00 to $20.00.

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com